{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:04:20Z","timestamp":1787497460357,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["INCT\/MCT\/CNPq\/CAPES\/FAPs n.197 - 16\/2014"],"award-info":[{"award-number":["INCT\/MCT\/CNPq\/CAPES\/FAPs n.197 - 16\/2014"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s42770-025-01833-4","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:48:48Z","timestamp":1765986528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DOT-MGA for rapid determination of susceptibility to the combination of Ceftazidime-avibactam and Aztreonam among Enterobacterales"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-6482","authenticated-orcid":false,"given":"Nat\u00e1lia Kehl","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-0769","authenticated-orcid":false,"given":"Gabriela","family":"da Silva Collar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5130-9057","authenticated-orcid":false,"given":"Mariana Preussler","family":"Mott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-1430","authenticated-orcid":false,"given":"Patricia Orlandi","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Gubert","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-3908","authenticated-orcid":false,"given":"Afonso Lu\u00eds","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8776-8447","authenticated-orcid":false,"given":"Juliana","family":"Caire\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"1833_CR1","unstructured":"WHO (2024) Bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. https:\/\/www.who.int\/publications. Accessed 25 April 2025"},{"key":"1833_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404:1199\u20131226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1","journal-title":"Lancet"},{"key":"1833_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/antibiotics9040186","volume":"9","author":"D Hammoudi Halat","year":"2020","unstructured":"Hammoudi Halat D, Ayoub Moubareck C (2020) The current burden of carbapenemases: review of significant properties and dissemination among Gram-Negative bacteria. Antibiotics 9:186. https:\/\/doi.org\/10.3390\/antibiotics9040186","journal-title":"Antibiotics"},{"key":"1833_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jgar.2024.03.020","volume":"37","author":"MG Wise","year":"2024","unstructured":"Wise MG, Karlowsky JA, Mohamed N et al (2024) Global trends in carbapenem- and difficult-to-treat-resistance among world health organization priority bacterial pathogens: ATLAS surveillance program 2018\u20132022. J Glob Antimicrob Resist 37:168\u2013175. https:\/\/doi.org\/10.1016\/j.jgar.2024.03.020","journal-title":"J Glob Antimicrob Resist"},{"key":"1833_CR5","doi-asserted-by":"publisher","unstructured":"Antochevis LC, Wilhelm CM, Arns B et al (2025) World Health Organization priority antimicrobial resistance in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecium healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational study. Lancet Reg Health Am 43:101004. https:\/\/doi.org\/10.1016\/j.lana.2025.101004","DOI":"10.1016\/j.lana.2025.101004"},{"key":"1833_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/JLP.JLP_76_17","volume":"10","author":"A Agarwal","year":"2018","unstructured":"Agarwal A, Srivastava J, Maheshwari U, Iftikhar M (2018) Molecular characterization and antimicrobial susceptibility profile of new Delhi metallo-beta-lactamase-1-producing Escherichia coli among hospitalized patients. J Lab Physicians 10:149\u2013154. https:\/\/doi.org\/10.4103\/JLP.JLP_76_17","journal-title":"J Lab Physicians"},{"key":"1833_CR7","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.3390\/ijms21239308","volume":"21","author":"JC V\u00e1zquez-Ucha","year":"2020","unstructured":"V\u00e1zquez-Ucha JC, Arca-Su\u00e1rez J, Bou G, Beceiro A (2020) New carbapenemase inhibitors: clearing the way for the \u03b2-Lactams. Int J Med Stud 21:9308. https:\/\/doi.org\/10.3390\/ijms21239308","journal-title":"Int J Med Stud"},{"key":"1833_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/antibiotics12101481","volume":"12","author":"L Razaq","year":"2023","unstructured":"Razaq L, Uddin F, Ali S et al (2023) In vitro activity of new \u03b2-Lactamase inhibitor combinations against blaNDM, blaKPC, and ESBL-Producing Enterobacterales uropathogens. Antibiotics 12:1481. https:\/\/doi.org\/10.3390\/antibiotics12101481","journal-title":"Antibiotics"},{"key":"1833_CR9","doi-asserted-by":"publisher","first-page":"e02569","DOI":"10.1128\/AAC.02569-17","volume":"62","author":"JA Karlowsky","year":"2018","unstructured":"Karlowsky JA, Kazmierczak KM, Bouchillon SK et al (2018) In vitro activity of Ceftazidime-Avibactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa collected in Asia-Pacific countries: results from the INFORM global surveillance Program, 2012 to 2015. Antimicrob Agents Chemother 62:e02569\u2013e02517. https:\/\/doi.org\/10.1128\/AAC.02569-17","journal-title":"Antimicrob Agents Chemother"},{"key":"1833_CR10","unstructured":"FDA (2025) Aztreonam and Avibactam Injection. Accessed 25 Feb 2025 http:\/\/www.fda.gov\/drugsatfda"},{"key":"1833_CR11","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","volume":"72","author":"M Falcone","year":"2021","unstructured":"Falcone M, Daikos GL, Tiseo G et al (2021) Efficacy of Ceftazidime-avibactam plus Aztreonam in patients with bloodstream infections caused by Metallo-\u03b2-lactamase\u2013Producing Enterobacterales. Clin Infect Dis 72:1871\u20131878. https:\/\/doi.org\/10.1093\/cid\/ciaa586","journal-title":"Clin Infect Dis"},{"key":"1833_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/antibiotics10081012","volume":"10","author":"C Mauri","year":"2021","unstructured":"Mauri C, Maraolo AE, Di Bella S et al (2021) The revival of Aztreonam in combination with avibactam against Metallo-\u03b2-Lactamase-Producing Gram-Negatives: A systematic review of in vitro studies and clinical cases. Antibiotics 10:1012. https:\/\/doi.org\/10.3390\/antibiotics10081012","journal-title":"Antibiotics"},{"key":"1833_CR13","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.2147\/IDR.S459695","volume":"17","author":"M Szyma\u0144ski","year":"2024","unstructured":"Szyma\u0144ski M, Skiba M, Piasecka M, Olender A (2024) Synergistic effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+. Infect Drug Resist 17:2307\u20132313. https:\/\/doi.org\/10.2147\/IDR.S459695","journal-title":"Infect Drug Resist"},{"key":"1833_CR14","doi-asserted-by":"publisher","first-page":"e00008","DOI":"10.1128\/cmr.00008-23","volume":"36","author":"L Ding","year":"2023","unstructured":"Ding L, Shen S, Chen J et al (2023) Klebsiella pneumoniae carbapenemase variants: the new threat to global public health. Clin Microbiol Rev 36:e00008\u201323. https:\/\/doi.org\/10.1128\/cmr.00008-23","journal-title":"Clin Microbiol Rev"},{"key":"1833_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1017\/ice.2021.6","volume":"43","author":"AM Trzebucki","year":"2022","unstructured":"Trzebucki AM, Westblade LF, Loo A et al (2022) Real-world implementation and impact of a rapid carbapenemase detection test in an area endemic for carbapenem-resistant Enterobacterales. Infect Control Hosp Epidemiol 43:92\u201395. https:\/\/doi.org\/10.1017\/ice.2021.6","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1833_CR16","doi-asserted-by":"publisher","first-page":"e01814","DOI":"10.1128\/JCM.01814-19","volume":"59","author":"EA Idelevich","year":"2021","unstructured":"Idelevich EA, Becker K (2021) Matrix-Assisted laser desorption Ionization\u2013Time of flight mass spectrometry for antimicrobial susceptibility testing. J Clin Microbiol 59:e01814\u2013e01819. https:\/\/doi.org\/10.1128\/JCM.01814-19","journal-title":"J Clin Microbiol"},{"key":"1833_CR17","unstructured":"ISO (2019) Clinical laboratory testing and in vitro diagnostic test systems - susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. https:\/\/www.iso.org\/ Accessed 25 April 2025."},{"key":"1833_CR18","unstructured":"EUCAST (2025) Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. http:\/\/www.eucast.org. Accessed 25 Apr 2025"},{"key":"1833_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/jac\/dkr563","volume":"67","author":"J Monteiro","year":"2012","unstructured":"Monteiro J, Widen RH, Pignatari ACC et al (2012) Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 67:906\u2013909. https:\/\/doi.org\/10.1093\/jac\/dkr563","journal-title":"J Antimicrob Chemother"},{"key":"1833_CR20","unstructured":"ISO (2007) 20776-2. Clinical laboratory testing and in vitro diagnostic test systems\u2014susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices\u2014part 2: evaluation of performance of antimicrobial susceptibility test devices. Accessed 25 April 2025 https:\/\/www.iso.org."},{"key":"1833_CR21","unstructured":"FDA (2009) Guidance for industry and FDA-Class II special controls guidance document: antimicrobial susceptibility test (AST) systems. Accessed 25 April 2025 https:\/\/www.fda.gov."},{"key":"1833_CR22","unstructured":"ANVISA (2022) NOTA T\u00c9CNICA No 74\/2022-CGLAB\/DAEVS\/SVS\/MS http:\/\/brcast.org.br. Accessed 25 April 2025"},{"key":"1833_CR23","doi-asserted-by":"publisher","unstructured":"Falcone M, Daikos GL, Tiseo G et al (2020) Efficacy of Ceftazidime-avibactam plus Aztreonam in patients with bloodstream infections caused by Metallo-\u03b2-lactamase\u2013Producing Enterobacterales. https:\/\/doi.org\/10.1093\/cid\/ciaa586. Clin Infect Dis ciaa586","DOI":"10.1093\/cid\/ciaa586"},{"key":"1833_CR24","doi-asserted-by":"publisher","first-page":"115227","DOI":"10.1016\/j.diagmicrobio.2020.115227","volume":"99","author":"M Lee","year":"2021","unstructured":"Lee M, Abbey T, Biagi M, Wenzler E (2021) Activity of Aztreonam in combination with ceftazidime\u2013avibactam against serine- and metallo-\u03b2-lactamase\u2013producing Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 99:115227. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115227","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1833_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-022-04523-3","author":"S Liu","year":"2022","unstructured":"Liu S, Lin Q, Ouyang L et al (2022) Successful treatment of ceftazidime\/avibactam combined with Aztreonam in the NDM-producing Klebsiella pneumoniae bloodstream and intestinal infections in a NK\/T lymphoma patient with agranulocytosis during autologous hematopoietic stem cell transplantation: a case report. Eur J Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1007\/s10096-022-04523-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1833_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jgar.2021.12.009","volume":"28","author":"KDO Lima","year":"2022","unstructured":"Lima KDO, De Lima AV, Rocha DADC et al (2022) A simple disk pre-diffusion test to predict in vitro aztreonam\/avibactam activity against NDM-producing Klebsiella pneumoniae complex. J Glob Antimicrob Resist 28:49\u201352. https:\/\/doi.org\/10.1016\/j.jgar.2021.12.009","journal-title":"J Glob Antimicrob Resist"},{"key":"1833_CR27","doi-asserted-by":"publisher","unstructured":"Collar GDS, Moreira NK, Becker J et al (2024) Determination of aztreonam\/ceftazidime-avibactam synergism and proposal of a new methodology for the evaluation of susceptibility in vitro. Diagn Microbiol Infect Dis 116236. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116236","DOI":"10.1016\/j.diagmicrobio.2024.116236"},{"key":"1833_CR28","doi-asserted-by":"publisher","first-page":"e00846","DOI":"10.1128\/AAC.00846-21","volume":"65","author":"A Khan","year":"2021","unstructured":"Khan A, Erickson SG, Pettaway C et al (2021) Evaluation of susceptibility testing methods for Aztreonam and Ceftazidime-Avibactam combination therapy on extensively Drug-Resistant Gram-Negative organisms. Antimicrob Agents Chemother 65:e00846\u2013e00821. https:\/\/doi.org\/10.1128\/AAC.00846-21","journal-title":"Antimicrob Agents Chemother"},{"key":"1833_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cmi.2017.10.016","volume":"24","author":"EA Idelevich","year":"2018","unstructured":"Idelevich EA, Sparbier K, Kostrzewa M, Becker K (2018) Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay. Clin Microbiol Infect 24:738\u2013743. https:\/\/doi.org\/10.1016\/j.cmi.2017.10.016","journal-title":"Clin Microbiol Infect"},{"key":"1833_CR30","doi-asserted-by":"publisher","first-page":"1075650","DOI":"10.3389\/fmicb.2022.1075650","volume":"13","author":"PO Barth","year":"2022","unstructured":"Barth PO, Volpato FCZ, Moreira NK et al (2022) Evaluation of a rapid susceptibility test of polymyxin B by MALDI-TOF. Front Microbiol 13:1075650. https:\/\/doi.org\/10.3389\/fmicb.2022.1075650","journal-title":"Front Microbiol"},{"key":"1833_CR31","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1038\/s41598-020-61890-7","volume":"10","author":"CL Correa-Mart\u00ednez","year":"2020","unstructured":"Correa-Mart\u00ednez CL, Idelevich EA, Sparbier K et al (2020) Development of a MALDI-TOF MS-based screening panel for accelerated differential detection of carbapenemases in Enterobacterales using the direct-on-target microdroplet growth assay. Sci Rep 10:4988. https:\/\/doi.org\/10.1038\/s41598-020-61890-7","journal-title":"Sci Rep"},{"key":"1833_CR32","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/diagnostics11101803","volume":"11","author":"EA Idelevich","year":"2021","unstructured":"Idelevich EA, Nix ID, Busch JA et al (2021) Rapid simultaneous testing of multiple antibiotics by the MALDI-TOF MS Direct-on-Target microdroplet growth assay. Diagnostics 11:1803. https:\/\/doi.org\/10.3390\/diagnostics11101803","journal-title":"Diagnostics"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-025-01833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-025-01833-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-025-01833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:29:45Z","timestamp":1774769385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-025-01833-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1007\/s42770-025-01833-4","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"19"}}